IGC Pharma
29 hedge funds and large institutions have $7.9M invested in IGC Pharma in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less capital invested
Capital invested by funds: $7.97M → $7.9M (-$70K)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Holders
29
Holding in Top 10
–
Calls
$1.19M
Puts
$568K
Top Buyers
| 1 | +$489K | |
| 2 | +$458K | |
| 3 | +$356K | |
| 4 |
VF
Virtu Financial
New York
|
+$312K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$102K |
Top Sellers
| 1 | -$572K | |
| 2 | -$212K | |
| 3 | -$135K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$125K |
| 5 |
BlackRock
New York
|
-$111K |